Analysis on the infection among patients with nephrotic syndromes and systemic vasculitis treated with mycophenolate mofetil.
Wang
Feng
F
Wang
Niansong
N
Li
Junhui
J
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015994:Incidence; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D009894:Opportunistic Infections / Q000453:epidemiology; D012141:Respiratory Tract Infections / Q000453:epidemiology*; D012307:Risk Factors; D056647:Systemic Vasculitis / Q000188:drug therapy*; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000453:epidemiology*
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid